The intestinotrophic peptide, glp-2, counteracts intestinal atrophy in mice induced by the epidermal growth factor receptor inhibitor, gefitinib.
intestinotrophic peptide glp-2 counteracts intestinal atrophy in mice induced by the epidermal growth factor receptor inhibitor gefitinib.